Samar Al-Behaisi

Dr Samar Al-Behaisi obtained her medical degree in Hungary and went on to complete a PhD, with a focus on clinical oncology and chemotherapy in oncology practice. She subsequently completed a degree in pharmaco-economics with a focus on reimbursement of orphan drugs. Dr Al-Behaisi joined the pharmaceutical industry in 1996, working initially for two Hungarian pharmaceutical companies as a clinical trial manager and medical advisor, then worked in Hungary with Novartis as senior medical marketing manager for oncology, GSK as oncology medical advisor and Genzyme as oncology medical director. Moving to Switzerland, she worked for five years at Takeda as oncology medical director for Europe and Canada where she was responsible for opinion-leader relationships, advisory boards and medical education programs, as well as pre-launch and launch activities for several oncology drugs. At Takeda, Dr Al-Behaisi was also responsible for handling, evaluating and approving doctor requests for oncology drugs under the company’s named patient program (NPP).
Bio last updated 16 May 2018

Article Timeline

Access to our data for Samar Al-Behaisi is only available to paid subscribers with access.

The search engine is Western Australia's most accurate and comprehensive business listings and searchable database.

Samar Al-Behaisi is linked to 1 organisation which is included in 1 list - Public Companies - Industrial.

To see the data you will need to .

Total Shareholder Return as at 30/04/18

1 year TSR5 year TSR
258thRace Oncology36%0%
721 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar


Chief Medical Officer, Vice President of Medical Affairs
Year started and most recent title


224th↓Race Oncology$0
238 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer